Other studies proved the higher expression of serum exosomal annexin A2 (AnxA2) in breast cancer patients, compared to non-cancer females (p < 0.0001), especially for TNBC, rather than luminal and HER2+ breast cancer. This evidence concerns the gene ANXA2 and breast cancer.